Marissa Sandhya Irene David, DPM
Podiatry · Anaheim
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Southern California Permanente Medical Group · 11,250 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. David’s office at (714) 279-6088 to ask if they take your plan before you enroll.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal or shaving of skin growth | 1-10 | None |
Medicaid work
$1,485 in 2024
Medicaid paid $1,485 for 120 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Debridement of nail(s) by any method(s); 6 or more | 12 | $1,485 |
| TOBACCO NON-USER | 108 | $0 |
| 2024 | 120 | 2 | 18 | $1,485 |
Drugs they prescribed that Part D paid
$8,187
Pharmacies billed $8,187 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 33% of their Part D prescriptions (144 of 439) in 2024. A higher opioid share than 9 in 10 peers; the typical podiatry clinician is at 5%. Long-acting opioids: 10% of their opioid prescriptions.
431 generic and fewer than 11 brand-name prescriptions · $8,187 in drug cost · 54 antibiotic prescriptions to 34 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 48 | $937 | $20 |
| Gabapentin | 64 | $780 | $12 |
| Morphine Sulfate Er | 14 | $600 | $43 |
| Oxycodone | 37 | $394 | $11 |
| Ibuprofen | 30 | $305 | $10 |
See all 12 drugs
| Hydrocodone-Acetaminophen | 48 | $937 | $20 |
| Gabapentin | 64 | $780 | $12 |
| Morphine Sulfate Er | 14 | $600 | $43 |
| Oxycodone | 37 | $394 | $11 |
| Ibuprofen | 30 | $305 | $10 |
| Amoxicillin-Clavulanate Potass | 16 | $236 | $15 |
| Tramadol | 35 | $229 | $7 |
| Terbinafine | 23 | $228 | $10 |
| Hydrocortisone | 16 | $196 | $12 |
| Meloxicam | 28 | $190 | $7 |
| Ondansetron Odt | 16 | $153 | $10 |
| Mupirocin | 13 | $127 | $10 |
Year by year
| 2024 | 439 | 136 | 33% (144) | None | $8,187 |
| 2023 | 336 | 121 | 29% (96) | None | $6,050 |
| 2022 | 310 | 108 | 34% (106) | None | $4,326 |
| 2021 | 283 | 136 | 15% (41) | None | $4,538 |
| 2020 | 146 | 80 | 11% (16) | None | $4,364 |
| 2019 | 28 | 22 | None | None | $1,364 |
| 2018 | 17 | 15 | 0% (0) | None | $435 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Gabapentin | 48 | $651 | $14 |
| Meloxicam | 64 | $427 | $7 |
| Oxycodone-Acetaminophen | 24 | $342 | $14 |
| Hydrocodone-Acetaminophen | 23 | $336 | $15 |
| Ibuprofen | 27 | $282 | $10 |
| Morphine Sulfate Er | 13 | $236 | $18 |
| Tramadol | 31 | $200 | $6 |
| Cephalexin | 12 | $139 | $12 |
| Doxycycline Monohydrate | 13 | $133 | $10 |
| Prednisone | 13 | $99 | $8 |
2022: 9 drugs
| Gabapentin | 56 | $725 | $13 |
| Diclofenac | 17 | $629 | $37 |
| Oxycodone-Acetaminophen | 46 | $461 | $10 |
| Hydrocodone-Acetaminophen | 37 | $343 | $9 |
| Meloxicam | 29 | $207 | $7 |
| Ciclopirox | 11 | $187 | $17 |
| Ibuprofen | 16 | $169 | $11 |
| Tramadol | 17 | $118 | $7 |
| Doxycycline Monohydrate | 11 | $116 | $11 |
2021: 8 drugs
| Diclofenac | 37 | $1,239 | $33 |
| Amoxicillin-Clavulanate Potass | 27 | $454 | $17 |
| Ciclopirox | 21 | $396 | $19 |
| Meloxicam | 50 | $345 | $7 |
| Prednisone | 12 | $210 | $18 |
| Gabapentin | 19 | $200 | $11 |
| Tramadol | 20 | $138 | $7 |
| Ibuprofen | 12 | $133 | $11 |
2020: 4 drugs
| Diclofenac | 16 | $730 | $46 |
| Amoxicillin-Clavulanate Potass | 13 | $265 | $20 |
| Gabapentin | 12 | $249 | $21 |
| Meloxicam | 29 | $182 | $6 |
Money from drug and device companies
$205 in 2025
| 2025 | 1 | 2 | None | $205 |
| 2023 | 2 | 3 | None | $162 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Prostep Mica | $205 | 2 payments
|
See all 2 published payments
| Stryker | Meals · 2025-09-24 | Prostep Mica | $154 |
| Stryker | Meals · 2025-08-20 | Prostep | $51 |
See earlier years (2023)
2023: $162
| Stryker | Citrefix | $144 | 2 payments
|
| Conetic Solutions | None | $18 | 1 payment
|
Professional record
- NPI
- 1780047589
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 700 Lawrence Expy, Santa Clara, CA, 95051
- NPI first listed
- 2016-03-30
- NPI last updated
- 2021-11-29
- NPI record certified
- 2021-11-29
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.